*with apologies for cross-posting*
Dear All
Further to the message below, we would like to clarify the situation with regards to Taylor & Francis, Informa Healthcare and related imprints.
There are no changes to the Taylor & Francis Group imprints. The Science and Technology journals are published under the Taylor & Francis imprint, all Social Science and Humanities journals under Routledge and all Behavioural journals under Psychology Press (collectively the Taylor & Francis Group). A list of the 1200+ journals available from Taylor & Francis Group is available at http://www.tandf.co.uk/journals/pdf/price.pdf, covering Science, Technology, Social Sciences, Arts and Humanities. For any queries please contact Ashleigh Bell at Taylor & Francis.
However, since 2006, all medical and pharmaceutical science journals have been published under the imprint of Informa Healthcare. A list of the 180+ journals available from Informa healthcare is available at http://catalogue.informahealthcare.com, covering Medicine and Allied Health. The change is that Informa Healthcare will now take on sales responsibility for their journals with effect from 1st January 2008. All existing signed licence agreements with Taylor & Francis which include Informa Healthcare journals will be honoured until expiry, after which the Medical element can be renewed through the Informa Healthcare team. For any queries please contact Brett Thomas, [log in to unmask], (UK, Europe, Middle East and South America) or Kevin Steiner, [log in to unmask], (North America and Asia).
Informa Healthcare also publishes a range of book titles principally in Medicine, Pharmaceutical Science and Toxicology. Informa Healthcare will take on sales responsibility for these books with effect from 1st January 2008. For all book enquiries in North America please contact Mike Rovins, for all book enquiries outside North America please contact Paul Abrahams. All the book imprints of the Taylor & Francis Group (including Routledge, CRC Press, Garland Science and Psychology Press) remain unaffected and customers should continue to contact their local Taylor & Francis representative.
Kind regards
Ashleigh Bell
Journals Sales Director
Taylor & Francis Group
[log in to unmask]
Brett Thomas
Sales Director
Informa Healthcare
[log in to unmask]
Original announcement:
Global media company Informa PLC is pleased to announce the strengthening of its Healthcare division through the exclusive management and selling of medical and life sciences books and journals, formerly sold via Taylor and Francis. Informa Healthcare's growing medical and scientific content offering, together with complete ownership of its sales channels, will allow it to serve its specialist customers with greater focus and efficiency.
With immediate effect, all enquiries relating to medical and life sciences publications from the following imprints should be directed to the Sales Division at Informa Healthcare: Marcel Dekker, Taylor & Francis, Routledge, CRC, Gordon & Breach, Swets & Zeitlinger and Ashley, Informa Healthcare
Informa Healthcare publishes leading-edge peer-reviewed journals, digital archives, databases, newsletters, books, directories and encyclopaedias.
Key Informa Healthcare titles include Scrip, Citeline, the Expert Opinion series, The Medical Directory, Drug Development and Industrial Pharmacy, Litt's Drug Eruption Reference Manual. For further information on the Informa Healthcare portfolio please go to www.informahealthcare.com
Kind regards
Brett Thomas
Sales Director, UK Medicine
Direct Tel.: +44 20 7017 5720
--------------------------------------------------------------------------------------------------------------------------------------------
The information contained in this email message may be confidential. If you are not the intended recipient, any use, interference with, disclosure or copying of this material is unauthorised and prohibited. Although this message and any attachments are believed to be free of viruses, no responsibility is accepted by Informa for any loss or damage arising in any way from receipt or use thereof. Messages to and from the company are monitored for operational reasons and in accordance with lawful business practices.
If you have received this message in error, please notify us by return and delete the message and any attachments. Further enquiries/returns can be sent to [log in to unmask]
|